Researchers at Simon Fraser University are using advanced brain imaging to uncover why Parkinson’s drug levodopa doesn’t help all patients equally. By using MEG (magnetoencephalography), they tracked real-time brain activity and discovered that the drug can sometimes activate the wrong brain regions—dampening its helpful effects. This insight could lead to personalized treatments tailored to each […]



Summary

Simon Fraser University researchers are using magnetoencephalography (MEG) to understand why the Parkinson’s drug levodopa has variable effects. Their research reveals that in some patients, levodopa activates incorrect brain regions, hindering its intended therapeutic benefits. By tracking real-time brain activity, the researchers aim to identify specific brain responses to levodopa. This understanding could pave the way for personalized treatment plans, ensuring patients receive targeted therapies that maximize the drug’s effectiveness based on their unique brain activity patterns. This could significantly improve treatment outcomes for individuals with Parkinson’s disease.

Read more…

This post is part of “Science and Technology News”, Follow for more…!!!